Clinical Study Report Release Could Compromise Patient Privacy, Groups Say
US FDA's plan to post CSRs may also inadvertently release confidential commercial information, agency is warned by industry groups.
US FDA's plan to post CSRs may also inadvertently release confidential commercial information, agency is warned by industry groups.